Patricia Vrignaud

2.6k total citations
57 papers, 1.8k citations indexed

About

Patricia Vrignaud is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Patricia Vrignaud has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 29 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Patricia Vrignaud's work include Cancer Treatment and Pharmacology (23 papers), Cancer therapeutics and mechanisms (11 papers) and Chemotherapy-induced cardiotoxicity and mitigation (10 papers). Patricia Vrignaud is often cited by papers focused on Cancer Treatment and Pharmacology (23 papers), Cancer therapeutics and mechanisms (11 papers) and Chemotherapy-induced cardiotoxicity and mitigation (10 papers). Patricia Vrignaud collaborates with scholars based in France, United States and Italy. Patricia Vrignaud's co-authors include François Lavelle, Jacques Robert, Marie-Christine Bissery, Jean‐François Riou, Cécile Combeau, Marie-Christine Bissery, Dorothée Sémiond, Hervé Bouchard, Pascale Lejeune and Danielle Londos‐Gagliardi and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Patricia Vrignaud

56 papers receiving 1.8k citations

Peers

Patricia Vrignaud

ONCOL

PRM

RNMI

Eleanor G. Zuhowski United States

William M. Merritt United States

Fernando Doñate United States

Vivien E. Prise United Kingdom

Gisele Sarosy United States

Tasneem Bawa‐Khalfe United States

Andreas Gschwind Germany

Daniele Avanzato Italy

Ruoxiang Wang United States

Joy Fisher United States

Eleanor G. Zuhowski United States

Patricia Vrignaud

718 ×0.8

ONCOL

1.0k ×1.5

383 ×1.3

PRM

212 ×0.9

81 ×0.5

RNMI

Citations per year, relative to Patricia Vrignaud Patricia Vrignaud (= 1×) peers Eleanor G. Zuhowski

Countries citing papers authored by Patricia Vrignaud

Since Specialization

Citations

This map shows the geographic impact of Patricia Vrignaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Vrignaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Vrignaud more than expected).

Fields of papers citing papers by Patricia Vrignaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Vrignaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Vrignaud. The network helps show where Patricia Vrignaud may publish in the future.

Co-authorship network of co-authors of Patricia Vrignaud

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Vrignaud. A scholar is included among the top collaborators of Patricia Vrignaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Vrignaud. Patricia Vrignaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nunes, Manoel, Patricia Vrignaud, Sophie Vacher, et al.. (2015). Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data. Cancer Research. 75(8). 1560–1566. 56 indexed citations

Durán, George E., Yan C. Wang, John C. Rose, et al.. (2014). Mechanisms of Resistance to Cabazitaxel. Molecular Cancer Therapeutics. 14(1). 193–201. 78 indexed citations

Vrignaud, Patricia, et al.. (2014). Preclinical profile of cabazitaxel. Drug Design Development and Therapy. 8. 1851–1851. 66 indexed citations

Vrignaud, Patricia, Dorothée Sémiond, Pascale Lejeune, et al.. (2013). Preclinical Antitumor Activity of Cabazitaxel, a Semisynthetic Taxane Active in Taxane-Resistant Tumors. Clinical Cancer Research. 19(11). 2973–2983. 191 indexed citations

Sémiond, Dorothée, Sukhvinder Sidhu, Marie-Christine Bissery, & Patricia Vrignaud. (2013). Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel. Cancer Chemotherapy and Pharmacology. 72(3). 515–528. 28 indexed citations

Geoerger, Birgit, Jean‐François Brasme, Estelle Daudigeos‐Dubus, et al.. (2010). Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastoma. European Journal of Cancer. 46(18). 3251–3262. 23 indexed citations

Lejeune, Pascale, Marielle Chiron, Ronan Le Moigne, Patricia Vrignaud, & Marie-Christine Bissery. (2008). Combination of the antiangiogenic agent aflibercept (VEGF Trap) with docetaxel or gemcitabine results in greater antitumor activity in tumor bearing mice.. Cancer Research. 68. 1107–1107. 6 indexed citations

Lejeune, Pascale, Valérie Rouffiac, Nicolas Elie, et al.. (2008). Early Quantitative Evaluation of a Tumor Vasculature Disruptive Agent AVE8062 Using Dynamic Contrast-Enhanced Ultrasonography. Investigative Radiology. 43(2). 100–111. 73 indexed citations

Lassau, Nathalie, et al.. (2007). Demonstration in animal and human of AVE8062-induced tumor blood flow shutdown using dynamic contrast enhanced-ultrasonography (DCE-US).. Cancer Research. 67. 2 indexed citations

10.

Chiron, Marielle, Patricia Vrignaud, Pascale Lejeune, et al.. (2007). Synergistic activity of aflibercept (VEGF Trap) in combination with 5-fluorouracil and irinotecan in preclinical tumor models. Molecular Cancer Therapeutics. 6. 10 indexed citations

11.

Vrignaud, Patricia, Marielle Chiron, Murray Stackhouse, et al.. (2007). In vivo synergy between trastuzumab (herceptin ® ) and larotaxel (RPR 109881A), a new taxoid.. Cancer Research. 67. 1432–1432. 2 indexed citations

12.

Guffroy, Magali, et al.. (2004). Evaluation of tissue perfusion (tumor, spleen, heart) in mice after administration of AVE8062, a tumor vascular-targeting agent. Cancer Research. 64. 1255–1255. 3 indexed citations

13.

Granda, Teresa G., Elisabeth Filipski, Patricia Vrignaud, Marie-Christine Bissery, & Françis Lévi. (2003). Rythme d’expression de la protéine BCL-2 chez la souris porteuse de l’adénocarcinome mammaire MA13/C. Pathologie Biologie. 51(4). 220–221. 1 indexed citations

14.

Granda, Teresa G., Elisabeth Filipski, Patricia Vrignaud, et al.. (2002). Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma. British Journal of Cancer. 86(6). 999–1005. 56 indexed citations

15.

Bissery, Marie-Christine, Hervé Bouchard, Jean‐François Riou, et al.. (2000). Preclinical evaluation of TXD258, a new taxoid. 41. 214. 30 indexed citations

16.

Bissery, Marie-Christine, Patricia Vrignaud, François Lavelle, & Guy G. Chabot. (1996). Preclinical Antitumor Activity and Pharmacokinetics of Irinotecan (CPT‐11) in Tumor‐bearing Mice. Annals of the New York Academy of Sciences. 803(1). 173–180. 14 indexed citations

17.

Ojima, Iwao, Olivier Duclos, Martine Zucco, et al.. (1994). Synthesis and Structure-Activity Relationships of New Antitumor Taxoids. Effects of Cyclohexyl Substitution at the C-3' and/or C-2 of Taxotere (Docetaxel). Journal of Medicinal Chemistry. 37(16). 2602–2608. 27 indexed citations

18.

Bissery, Marie-Christine, Chi Hung Nguyen, Émile Bisagni, Patricia Vrignaud, & François Lavelle. (1993). Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice. Investigational New Drugs. 11(4). 263–277. 14 indexed citations

19.

Sangalli, Francesca, Patricia Vrignaud, Jacques Robert, J.M. Coindre, & F Cohadon. (1989). Assessment of the experimental model of transplanted C6 glioblastoma in wistar rats. Journal of Neuro-Oncology. 7(3). 299–304. 66 indexed citations

20.

Vrignaud, Patricia, et al.. (1988). Alteration of ganglioside composition and metabolism in doxorubicin-resistant rat tumoral cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 963(3). 553–557. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact